Two Report Options
Integrated Molecular and First-line Results
Molecular-only Results
Look Below the Surface
With Molecular Testing
Two Report Options
Integrated Molecular and First-line Results
Molecular-only Results
Look Below the Surface
With Molecular Testing
Resources
Downloads
Key Publications
The Diagnostic Yield of Malignancy Comparing Cytology, FISH, and Molecular Analysis of Cell Free Cytology Brush Supernatant in Patients With Biliary Strictures Undergoing Endoscopic Retrograde Cholangiography (ERC), A Prospective Study
Kushnir VM, Mullady DK, Das K, et al. J Clin Gastroenterol. 2019;53(9):686-692. DOI: 10.1097/MCG.0000000000001118.
Mutation Profile and Fluorescence In Situ Hybridization Analyses Increase Detection of Malignancies in Biliary Strictures
Gonda TA, Viterbo D, Gausman V, et al. Clin Gastroenterol Hepatol. 2017;15:913-919.
Incremental value of DNA analysis in pancreatic cysts stratified by clinical risk factors
Farrell JJ, Al-Haddad MA, Jackson SA, Gonda TA. Gastrointest Endosc. 2019;89:832-841.
Molecular analysis of pancreatic cyst fluid changes clinical management
Arner DM, Corning BE, Ahmed AM, Ho HC, Weinbaum BJ, et al. Endosc Ultrasound. 2018;7:29-33.
Influence of integrated molecular pathology test results on real-world management decisions for patients with pancreatic cysts: analysis of data from a national registry cohort
Loren D, Kowalski T, Siddiqui A, Jackson S, Toney N, et al. Diagn Pathol. 2016;11:5.
Integrated molecular pathology accurately determines the malignant potential of pancreatic cysts
Al-Haddad MA, Kowalski T, Siddiqui A, Mertz HR, Mallat D, et al. Endoscopy. 2015; 47(2):136-46
